Thu, Dec 25, 2014
A A A
Welcome Guest
Free Trial RSS
Get FREE trial access to our award winning publications
Opalesque Radio

Brent Crude as a Benchmark
Radio Feature 43: Jean-Luc Amos in conversation with Sona Blessing
 
Tuesday, March 27, 2012
radio Jean-Luc's role at Intercontinental Exchange, ICE, Futures Europe entails facilitating the development, growth and promotion of ICE’s new and existing energy Futures and OTC markets. Prior to joining ICE, he worked at Platts as a forward curve and futures editor. In this radio feature he elaborates on why Brent Crude has emerged as the reference crude oil benchmark, volumes traded over the last 12 months, how it compares with other benchmarks such as WTI and Dubai, and tells us more about why their latest product was launched.

 Download this feature as MP3 (6.11 MB)

 
Listen to the complete feature
Brent Crude as a Benchmark

Duration: 06:40 

 

Or listen to selected sub-features
  • Q1 - Why is Brent Crude being used as a benchmark?

    Duration: 01:11 


  • Q2 - What has been and led to the growth in volumes experienced in ICE Brent Futures over the last 12 months – would you say there has there been a rise in “hedgies” since the Iran embargo was announced … and how does this compare with other futures traded in the oil complex?

    Duration: 01:44 


  • Q3 - Why has the spread between Brent Crude and the WTI been widening over the last few years?

    Duration: 01:16 


  • Q4 - How does Brent Crude as a benchmark compare with the Dubai benchmark?

    Duration: 00:59 


  • Q5 - Can you tell us more about the latest product you have launched?

    Duration: 01:29 



Radio Link
  • Top Forwarded
  • Top Tracked
  • Top Searched
  1. Hong Kong-Shanghai stock link fails to live up to expectation so far[more]

    Komfie Manalo, Opalesque Asia: In a report, Reuters said that demand has been subdued with the bulk of activities coming from short-term speculative investors. Las

  2. Investing - Hedge funds get boost from healthcare in 2014, Paulson & Co takes stake in Salix on heels of inventory issues[more]

    Hedge funds get boost from healthcare in 2014 From Valuewalk.com: The healthcare sector started the year on a turbulent note, as stocks of many major biotechnology companies were battered. However, most of the players in this sector have bounced back. The BarclayHedge Healthcare & Biotec

  3. North America - Why Steve Cohen, Connecticut hedge fund billionaire, gives so much in New York[more]

    From Insidephilantrophy.com: Billionaire Steve Cohen was born in Great Neck, New York before attending Wharton, working on Wall Street and then founding SAC Capital Advisors in Connecticut. Though his company (Point72) and foundation are based in Connecticut, Cohen and Alexandra are deeply connected

  4. Investing - Soros buys a highly speculative biotech in the third quarter[more]

    From Fool.com: …The Soros Fund bought 25,000 shares of the struggling small-cap biopharma Aegerion Pharmaceuticals in the third quarter. For those of you who haven't heard of this name, suffice to say that this was a surprising buy in light of the company's recent problems and poor outlook going for

  5. CFTC Revokes Registrations of Illinois Resident Aleks A. Kins and Chicago-based AlphaMetrix, LLC[more]

    Matthias Knab, Opalesque: The U.S. Commodity Futures Trading Commission (CFTC) today announced that it has revoked the registration of Aleks A. Kins of Chicago, Illinois, as an Associated Person and the registrations of AlphaMetrix, LLC (AlphaMetrix), a Delaware limited liability company with its